Healthcare Equipment and Supplies
Company Overview of Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc., a medical technology company, engages in the development, sale, and service of proton beam radiation therapy systems for radiation treatment of cancer patients. It offers MEVION S250, a proton radiation therapy device for use in patient imaging, positioning, monitoring, motion management, and clinical workflow. The company markets its product to a range of customers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers worldwide. It has strategic partnership with RaySearch Laboratories AB to develop advanced treatment planning solutions. Mevion Medical Systems, Inc....
300 Foster Sreet
Littleton, MA 01460
Founded in 2004
Key Executives for Mevion Medical Systems, Inc.
Chief Executive Officer, President and Director
Chief Financial Officer and Vice President
Vice President of Operations
Vice President of Regulatory Affairs & Quality Assurance and Administration
Compensation as of Fiscal Year 2015.
Mevion Medical Systems, Inc. Key Developments
Mevion to Install Three-Room Proton Therapy System in Los Angeles
Nov 19 15
Mevion Medical Systems is announcing the Los Angeles Proton Center is building a three-room MEVION S250mx Proton Therapy System. The system will include Mevion’s HYPERSCAN pencil beam scanning technology and will be installed near Los Angeles, in the city of Montebello, on the campus of Beverly Hospital. The installation will take place in phases, with the first of the three rooms treating cancer patients in late 2017. A rendering of the Los Angeles Proton Center in Montebello, Calif., where a three-room MEVION S250mx proton therapy system will begin treating patients in 2017. The MEVION S250mx is the fully scalable version of Mevion’s revolutionary proton therapy technology and is available in two, three or four room configurations. Each room is fully independent, with its own proton accelerator, providing inherent redundancy and 100% facility uptime 365 days per year. Similar Mevion systems have ramped up to full capacity in as little as three months and achieved an annualized rate of 350 patients per room, per year. That is more than 25% better than the average U.S. proton therapy center. The Los Angeles system is the third system purchase announced by Mevion in the past six weeks. In October, Mevion announced the installation of a MEVION S250 to Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, and a MEVION S250i with HYPERSCAN to the Ackerman Cancer Center in Jacksonville, Florida.
Ackerman Cancer Center to Install Second Mevion Medical Systems's S250 Proton Therapy System
Oct 14 15
Mevion Medical Systems announced that Ackerman Cancer Center (ACC) will install a second MEVION S250 Series proton therapy system. The second ACC system is a MEVION S250i with HYPERSCAN pencil beam scanning technology, which delivers high-quality Intensity Modulated Proton Therapy (IMPT) treatments with precision and robustness. Mevion's HYPERSCAN technology operates at unmatched speeds -- volumetrically scanning tumors in less than six seconds -- eliminating many of the challenges caused by patient motion that traditional pencil beam scanning solutions encounter. Its tumor targeting capability is further enhanced by its extremely low lateral penumbra.
Mevion Medical Systems, Inc. to Secure $200 Million in Financing
Aug 5 15
Mevion Medical Systems, Inc. has entered into an investment agreement to secure approximately $200 million in financing led by HOPU Investments, YuanMing Capital, with participation from Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners. Mevion will use the funds to accelerate its worldwide expansion.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 24, 2015